Reflections on gut decontamination in hematology.

Area of Science:

• Oncology
• Infectious Diseases
• Hematology

Background:

• Digestive decontamination (GD) is a common practice in European oncohematology for preventing bacterial infections in neutropenic patients.
• Its use is particularly prevalent in patients with profound neutropenia, such as those undergoing bone marrow transplantation or acute leukemia induction chemotherapy.
• Quinolone-based regimens have partially replaced older non-absorbable antibiotic treatments for GD.

Purpose of the Study:

• To re-examine the correlation between existing literature data and current clinical practices regarding digestive decontamination (GD).
• To highlight the main challenges and controversies surrounding the use of digestive decontamination (DD) in oncohematology.
• To gather expert opinions on the value and application of GD in neutropenic patients.

Main Methods:

• A multidisciplinary meeting of experts was convened in Paris in October 1996.
• Experts were divided into three working groups to draft reports on GD.
• The meeting aimed to review literature and clinical practice, not to reach a formal consensus.

Main Results:

• Despite widespread use in Europe (45-73% of febrile neutropenic patients receive GD), the clinical value of GD is controversial.
• Numerous trials in the 1980s did not establish a medical consensus on GD's efficacy.
• GD use is infrequent in the USA, and few studies have been published in the last decade.

Conclusions:

• There is a lack of consensus on the value of digestive decontamination (GD) in neutropenic patients.
• Clinical practice regarding GD has remained largely unchanged despite limited recent evidence.
• Further examination of GD's correlation with literature data and clinical practice is needed to address current challenges in oncohematology.